DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

MannKind Corp (NASDAQ: MNKD)



company name or ticker

MannKind Stock Approaching Pre-FDA Approval Price: Is A Bottom Coming?

Investors' Love/Hate Relationship with MannKind Corp. Stock

Emotions run high when it comes to this biotech.

Major Biotech Is So-So for Short Sellers

Analyst: MannKind Afrezza Estimates Are Being Changed 'Based On Physician Feedback'

Early Adopters Embrace Afrezza, As New Inhaled Insulin Enters Market

Did Researchers Just Unlock a Type 1 Diabetes Cure?

Forget just trying to treat the symptoms of type 1 diabetes! According to the findings from this latest study, a type 1 diabetes cure may be possible.

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

Benzinga's Top #PreMarket Losers

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

MannKind's Financial Health Complicated by Looming $100M Debt Payment

See More Articles...